Minnesota Oncology is pleased to introduce our new breast surgeon, Elizabeth O’Leary, MD, FACS

“My most important role is taking care of my patients and providing a safe, reassuring place that will help them to easily navigate the confusing world of cancer, cancer therapies and benign breast diseases. My patients come first and my greatest reward comes from being able to help patients through their most trying times, getting them to the other side and bringing a smile back to their hearts and faces.”

Dr. O’Leary joins Minnesota Oncology ‘s new breast surgical services. Dr. O’Leary holds a Masters of Health Science in International Health, Disease Control and Prevention Track from Johns Hopkins Bloomberg School of Public Health in Baltimore, MD.  She completed her residency at MedStar Washington Hospital Center, doing rotations at Georgetown University, Washington, D.C.

Her areas of special interest include:

  • Breast cancer 
  • Benign breast diseases  
  • Cancer genetics 
  • High risk breast cancer screening andrisk reduction 
  • Ultrasound-guided / Minimally-invasive breast biopsies and interventions 

Other Interests include: Thyroid and parathyroid, skin cancer and benign masses, other surgical oncology procedures, minimally invasive biopsies, general surgery procedures

Learn more about Dr. O’Leary and request an appointment here.

Share

Categories

Tags

Recent Posts

#
June 3, 2025

Reflecting on her experience with Minnesota Oncology, Diane is filled with gratitude. “If you find yourself in the involuntary ‘cancer club,’ there is no better place to be than Minnesota Oncology.

#
May 28, 2025

This is the story about the origin of the Angel Foundation. Minnesota Oncology has long supported the Angel Foundation through sponsorships, employee-driven fundraisers, volunteerism, and payroll deduction. But many may not know why our two organizations are so close and how the foundation started.

#
May 19, 2025

Exposure to bacteria may contribute to rising rates of colorectal cancer in young adults. Colorectal cancer has moved from being the fourth leading of cause of cancer related death in both men and women under the age of 50 two decades ago to being number one in men and second in women.